Vaxcyte (PCVX) Times Interest Earned (2019 - 2022)
Vaxcyte (PCVX) reported Times Interest Earned of -$23943.0 for Q2 2022, down 606.28% year-over-year from $4729.2 in Q2 2021, and down 606.28% quarter-over-quarter from -$3390.0 in Q2 2021.
Vaxcyte (PCVX) Times Interest Earned (2019 - 2022) Analysis & Trends
Vaxcyte (PCVX) has 4 years of Times Interest Earned data on file, last reported at -$23943.0 in Q2 2022.
- Times Interest Earned for Q2 2022 came in at -$23943.0, down 606.28% year-over-year; the trailing twelve-month figure through Mar 2023 was -$132114.0 (down 672.29% YoY), and the FY2022 annual result was -$116128.0, down 684.12% from the prior year.
- Times Interest Earned fell to -$23943.0 in Q2 2022 per PCVX's latest filing, from -$3390.0 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$1112.0 in Q2 2019 and troughed at -$23943.0 in Q2 2022.
- A 4-year average of -$5999.8 and a median of -$2826.2 in 2019 frame the typical range for Times Interest Earned.
- On a YoY basis, Times Interest Earned climbed as much as 606.28% in 2022 and fell as far as 606.28% in 2022.
- A 4-year view of Times Interest Earned shows it stood at -$2262.4 in 2019, then slumped by 74.25% to -$3942.3 in 2020, then advanced by 14.01% to -$3390.0 in 2021, then plunged by 606.28% to -$23943.0 in 2022.
- Business Quant data shows PCVX's Times Interest Earned at -$23943.0 in Q2 2022, -$3390.0 in Q2 2021, and -$3942.3 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -258.33 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 11.79 |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -23,943.00 |
| Jun 30, 2021 | -3,390.00 |
| Mar 31, 2020 | -3,942.29 |
| Dec 31, 2019 | -2,262.43 |
| Sep 30, 2019 | -1,348.89 |
| Jun 30, 2019 | -1,112.00 |